The effect of thickened-feed interventions on gastroesophageal reflux in infants: systematic review and meta-analysis of randomized, controlled trials
- PMID: 19001038
- DOI: 10.1542/peds.2008-1900
The effect of thickened-feed interventions on gastroesophageal reflux in infants: systematic review and meta-analysis of randomized, controlled trials
Erratum in
- Pediatrics. 2009 Apr;123(4):1254
Abstract
Context: Currently, thickened feeds are increasingly being used to treat infants with gastroesophageal reflux, driven in large part by the baby food industry. Previous meta-analyses have shown that although thickened formulas do not seem to reduce measurable reflux, they may reduce vomiting. However, because data are limited, there is still uncertainty regarding the use of thickening agents.
Objective: Our goal was to systematically evaluate and update data from randomized, controlled trials on the efficacy and safety of thickened feeds for the treatment of gastroesophageal reflux in healthy infants.
Methods: The Cochrane Library, Medline, Embase, and CINAHL databases and proceedings of the European and North American pediatric gastroenterology conferences (from 2000) were searched in May 2008; additional references were obtained from reviewed articles. Only randomized, controlled trials that evaluated thickened feeds used in infants for at least several days for the treatment of gastroesophageal reflux were considered for inclusion. Three reviewers independently performed data extraction by using standard data-extraction forms. Discrepancies between reviewers were resolved by discussion between all authors. Only the consensus data were entered.
Results: Fourteen randomized, controlled trials with a parallel or crossover design, some with methodologic limitations, were included. Use of thickened formulas compared with standard formula significantly increased the percentage of infants with no regurgitation, slightly reduced the number of episodes of regurgitation and vomiting per day (assessed jointly or separately), and increased weight gain per day; it had no effect on the reflux index, number of acid gastroesophageal reflux episodes per hour, or number of reflux episodes lasting >5 minutes but significantly reduced the duration of the longest reflux episode of pH<4. No definitive data showed that one particular thickening agent is more effective than another. No serious adverse effects were noted.
Conclusions: This meta-analysis shows that thickened food is only moderately effective in treating gastroesophageal reflux in healthy infants.
Comment in
-
Thickened infant formula does what it has to do: decrease regurgitation.Pediatrics. 2009 Mar;123(3):e549-50; author reply e550. doi: 10.1542/peds.2008-3815. Pediatrics. 2009. PMID: 19254995 No abstract available.
-
Thickened formula is only moderately effective in the treatment of gastroesophageal reflux in healthy infants.J Pediatr. 2009 May;154(5):774. doi: 10.1016/j.jpeds.2009.02.043. J Pediatr. 2009. PMID: 19364566 No abstract available.
Similar articles
-
Feed thickener for infants up to six months of age with gastro-oesophageal reflux.Cochrane Database Syst Rev. 2017 Dec 5;12(12):CD003211. doi: 10.1002/14651858.CD003211.pub2. Cochrane Database Syst Rev. 2017. PMID: 29207214 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
Cited by
-
Neonatal gastroesophageal reflux.Early Hum Dev. 2022 Aug;171:105600. doi: 10.1016/j.earlhumdev.2022.105600. Epub 2022 Jun 10. Early Hum Dev. 2022. PMID: 35716649 Free PMC article. No abstract available.
-
The viscosity-enhancing effect of carob bean gum and sodium carboxymethylcellulose when added to infant formula.Food Sci Nutr. 2024 Jan 11;12(4):2661-2670. doi: 10.1002/fsn3.3947. eCollection 2024 Apr. Food Sci Nutr. 2024. PMID: 38628187 Free PMC article.
-
A narrative review of gastroesophageal reflux in the pediatric patient.Transl Gastroenterol Hepatol. 2021 Jul 25;6:34. doi: 10.21037/tgh-20-245. eCollection 2021. Transl Gastroenterol Hepatol. 2021. PMID: 34423155 Free PMC article. Review.
-
Acid Suppression Does Not Improve Laryngomalacia Outcomes but Treatment for Oropharyngeal Dysphagia Might Be Protective.J Pediatr. 2021 Nov;238:42-49.e2. doi: 10.1016/j.jpeds.2021.06.051. Epub 2021 Jun 26. J Pediatr. 2021. PMID: 34186104 Free PMC article.
-
Anti-regurgitation infant formulas and antacid medication: match or mismatch?Eur J Pediatr. 2025 May 13;184(6):336. doi: 10.1007/s00431-025-06161-1. Eur J Pediatr. 2025. PMID: 40355562
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical